Share-based Compensation (Tables)

9 Months Ended

Sep. 30, 2025

Share-based Compensation

Schedule of assumptions used in estimating the fair value of stock options

	Nine Months Ended
	September 30,
	2025	2024
Expected volatility	123%	47% – 87%
Risk-free interest rate	3.9%	3.7% – 4.3%
Expected life (in years)	6.25	5.27 – 6.25
Expected dividend yield	—	—

ABP Sub Inc. 2019 Incentive Award Plan

Share-based Compensation

Schedule of stock option activity

		Weighted
		Average
	Number of	Exercise
	Shares	Price
Outstanding, January 1, 2025	47,955	$	720.00
Options granted	—		—
Options forfeited	—		—
Outstanding, September 30, 2025	47,955	$	720.00
Exercisable, September 30, 2025	44,595	$	720.00

Summary of restricted stock units activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
Outstanding, January 1, 2025	11,398	$	780.48
Granted	—		—
Vested	(1,639)		—
Forfeited	—		—
Outstanding, September 30, 2025	9,759	$	780.48

AEON Biopharma Inc 2023 Incentive Award Plan

Share-based Compensation

Schedule of stock option activity

		Weighted
		Average
	Number of	Exercise
	Shares	Price
Outstanding, January 1, 2025	51,016	$	242.14
Options granted	—		—
Options forfeited	—		—
Outstanding, September 30, 2025	51,016	$	242.14
Exercisable, September 30, 2025	32,426	$	—

Summary of restricted stock units activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
Outstanding, January 1, 2025	14,215	$	60.05
Granted	—		—
Vested	—		—
Forfeited	—		—
Outstanding, September 30, 2025	14,215	$	60.05